A marked and heterogenous elevation in PRLR was previously reported in other types of tumors including breast cancer [33], prostate cancer [34], hepatocellular carcinoma [35] and glioblastoma multiforme [19]. This evidence concerns the gene PRLR and Familial prostate cancer.